Amyloid Levels News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CAMBRIDGE, Mass., March 11, 2022(Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, as well as data for ADUHELM (aducanumab-avwa) injection 100 mg/mL for intravenous use

United kingdomComunidad autonoma de catalunaAshleigh kossMike henckeWalter gilbertCharles weissmannHeinz schallerKenneth murrayInternational conference on alzheimerEisai co ltdExchange commissionInternational conferenceAmyloid levelsCognitive declineRandomized clinical trialsGlobal statistical tests